The U.S. Food and Drug Administration (FDA) has approved Forfivo XL, for patients with Major Depressive Disorder. Forfivo XL is a novel, high-strength formulation of bupropion hydrochloride, the active ingredient in Wellbutrin XL. Forfivo XL is the only single dose 450 mg formulation of bupropion hydrochloride approved by the FDA.
Forfivo XL is used primarily as a treatment for various forms of depression and can be used to treat other ailments such as smoking cessation. It may also be used for Seasonal Affective Disorder (SAD). Forfivo XL's main ingredient is bupropion. This is sold under many brand names, so you should make sure you are not taking other bupropion medications before beginning Forfivo XL.